Skip to main content
. 2019 Jun 10;7:e7091. doi: 10.7717/peerj.7091

Table 2. Univariate and multivariate analysis of SERPINE1 mRNA level and survival in TCGA STAD dataset.

Variable Univariate analysis Multivariate analysis3
HR1 95%CI2 p-value HR 95%CI p-value
Overall survival (n = 351)
Gender
 Male (n = 220) 1.325 0.924–1.900 0.125
 Female (n = 131)
Age (years)
 >60 (n = 234) 1.731 1.182–2.533 0.005 2.076 1.407–3.062 0.000
 ≤60 (n = 117)
T stage
 T3/T4 (n = 263) 1.715 1.109–2.652 0.015 1.198 0.720–1.994 0.486
 T1/T2 (n = 88)
N stage
 N1/2/3 (n = 241) 1.906 1.259–2.885 0.002 1.405 0.797–2.478 0.240
 N0 (n = 110)
M stage
 M1 (n = 24) 1.945 1.074–3.523 0.028 1.993 1.073–3.702 0.029
 M0 (n = 327)
TNM stage
 Stage III/IV (n = 193) 1.944 1.359–2.779 0.000 1.325 0.764–2.298 0.316
 Stage I/II (n = 158)
G grade
 G3 (n = 226) 1.434 1.002–2.052 0.049 1.452 1.006–2.094 0.046
 G1/G2 (n = 125)
SERPINE1
 High (n = 176) 1.941 1.377–2.737 0.000 1.843 1.305–2.603 0.001
 Low (n = 175)
Disease-free survival (n = 280)
Gender
 Male (n = 178) 2.179 1.357–3.497 0.001 2.021 1.256–3.252 0.004
 Female (n = 102)
Age (years)
 >60 (n = 175) 0.999 0.670–1.490 0.996
 ≤60 (n = 105)
T stage
 T3/T4 (n = 204) 1.408 0.882–2.247 0.151
 T1/T2 (n = 76)
N stage
 N1/2/3 (n = 182) 1.774 1.121–2.807 0.014 1.658 0.925–2.973 0.089
 N0 (n = 98)
M stage
 M1 (n = 16) 1.482 0.647–3.393 0.352
 M0 (n = 264)
TNM stage
 Stage III/IV (n = 142) 1.500 1.007–2.234 0.046 1.030 0.620–1.711 0.908
 Stage I/II (n = 138)
G grade
 G3 (n = 176) 1.198 0.795–1.805 0.388
 G1/G2 (n = 104)
SERPINE1
 High (n = 140) 1.800 1.206–2.687 0.004 1.755 1.175–2.621 0.006
 Low (n = 140)

Notes:

1

Hazard ratio.

2

Confidence interval of the HR.

3

Multivariate analysis of SERPINE1 was adjusted for included data like T, N, M stages, G grades, age or gender.